Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcripts

Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcripts

US Patent 11452738 · Granted Sep 27, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of angiopoietin like 7 (ANGPTL7) related diseases2025
Treatment of angiopoietin like 7 (ANGPTL7) related diseases2025
Treatment of angiopoietin like 7 (ANGPTL7) related diseases2025
Treatment of angiopoietin like 7 (ANGPTL7) related diseases2025
Treatment of angiopoietin like 7 (ANGPTL7) related diseases2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
Treatment of MST1 related diseases and disorders2025
Treatment of MST1 related diseases and disorders2025
Treatment of MST1 related diseases and disorders2025
Treatment of MST1 related diseases and disorders2025
Treatment of MST1 related diseases and disorders2025
Modified oligonucleotides2025